Lutz Nährlich
About
In The Last Decade
Lutz Nährlich
20 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Pulmonary and Respiratory Medicine 1.0k
- Molecular Biology 496
- Epidemiology 144
- Physiology 139
- Genetics 137
Countries citing papers authored by Lutz Nährlich
This map shows the geographic impact of Lutz Nährlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lutz Nährlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lutz Nährlich more than expected).
Fields of papers citing papers by Lutz Nährlich
This network shows the impact of papers produced by Lutz Nährlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lutz Nährlich. The network helps show where Lutz Nährlich may publish in the future.
Co-authorship network of co-authors of Lutz Nährlich
This figure shows the co-authorship network connecting the top 25 collaborators of Lutz Nährlich. A scholar is included among the top collaborators of Lutz Nährlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lutz Nährlich. Lutz Nährlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 5 | |
| 9 | 3 | |
| 10 | 75 | |
| 11 | 65 | |
| 12 | 3 | |
| 13 | 19 | |
| 14 | 11 | |
| 15 | 23 | |
| 16 | 0 | |
| 17 | Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study breakdown → | 1203 |
| 18 | 25 | |
| 19 | 9 | |
| 20 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.